363 related articles for article (PubMed ID: 17890448)
21. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
[TBL] [Abstract][Full Text] [Related]
22. Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade.
Roberts W; Magwenzi S; Aburima A; Naseem KM
Blood; 2010 Nov; 116(20):4297-306. PubMed ID: 20664056
[TBL] [Abstract][Full Text] [Related]
23. Reassessment of protein tyrosine phosphorylation in thrombasthenic platelets: evidence that phosphorylation of cortactin and a 64-kD protein is dependent on thrombin activation and integrin alphaIIb beta3.
Rosa JP; Artçanuthurry V; Grelac F; Maclouf J; Caen JP; Lévy-Toledano S
Blood; 1997 Jun; 89(12):4385-92. PubMed ID: 9192762
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
[TBL] [Abstract][Full Text] [Related]
25. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
[TBL] [Abstract][Full Text] [Related]
26. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
Li Z; Ajdic J; Eigenthaler M; Du X
Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
[TBL] [Abstract][Full Text] [Related]
27. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation.
Schinner E; Salb K; Schlossmann J
Platelets; 2011; 22(3):217-27. PubMed ID: 21244222
[TBL] [Abstract][Full Text] [Related]
28. Decreasing phosphodiesterase 5A activity contributes to platelet cGMP accumulation during storage of apheresis-derived platelet concentrates.
Kobsar A; Putz E; Yilmaz P; Weinig E; Boeck M; Koessler J
Transfusion; 2014 Apr; 54(4):1008-14. PubMed ID: 23909451
[TBL] [Abstract][Full Text] [Related]
29. Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa.
Horn M; Bertling A; Brodde MF; Müller A; Roth J; Van Aken H; Jurk K; Heilmann C; Peters G; Kehrel BE
J Thromb Haemost; 2012 Apr; 10(4):647-61. PubMed ID: 22268819
[TBL] [Abstract][Full Text] [Related]
30. Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets.
Hoffmeister M; Riha P; Neumüller O; Danielewski O; Schultess J; Smolenski AP
J Biol Chem; 2008 Jan; 283(4):2297-306. PubMed ID: 18039662
[TBL] [Abstract][Full Text] [Related]
31. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
[TBL] [Abstract][Full Text] [Related]
32. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation.
Stojanovic A; Marjanovic JA; Brovkovych VM; Peng X; Hay N; Skidgel RA; Du X
J Biol Chem; 2006 Jun; 281(24):16333-9. PubMed ID: 16613861
[TBL] [Abstract][Full Text] [Related]
33. Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow.
Lagadec P; Dejoux O; Ticchioni M; Cottrez F; Johansen M; Brown EJ; Bernard A
Blood; 2003 Jun; 101(12):4836-43. PubMed ID: 12609828
[TBL] [Abstract][Full Text] [Related]
34. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
35. Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide.
Riba R; Patel B; Aburima A; Naseem KM
J Thromb Haemost; 2008 Dec; 6(12):2121-31. PubMed ID: 18983522
[TBL] [Abstract][Full Text] [Related]
36. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
[TBL] [Abstract][Full Text] [Related]
37. Platelet activity is negatively modulated by tumor necrosis factor alpha through reductions of cytosolic calcium levels and integrin alphaIIbbeta3 phosphorylation.
Bonfitto PHL; Naime ACA; Lopes-Pires ME; Goulart G; Mendes-Silverio CB; Bueno PI; Castilho RF; Antunes E; Marcondes S
Thromb Res; 2018 Dec; 172():44-50. PubMed ID: 30359790
[TBL] [Abstract][Full Text] [Related]
38. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
[TBL] [Abstract][Full Text] [Related]
39. cGMP and cGMP-dependent protein kinase in platelets and blood cells.
Walter U; Gambaryan S
Handb Exp Pharmacol; 2009; (191):533-48. PubMed ID: 19089344
[TBL] [Abstract][Full Text] [Related]
40. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3.
Li Z; Zhang G; Feil R; Han J; Du X
Blood; 2006 Feb; 107(3):965-72. PubMed ID: 16210341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
